Takeda Pharmaceutical (TAK) Other Non Operating Income (2017 - 2019)
Takeda Pharmaceutical's (TAK) quarterly Other Non Operating Income came in at $285.5 million in Q1 2019, up 150.74% quarter-over-quarter from -$562.8 million in Q4 2018.
Takeda Pharmaceutical (TAK) Other Non Operating Income (2017 - 2019) Analysis & Trends
Takeda Pharmaceutical's Other Non Operating Income history runs 3 years deep, the most recent figure standing at $285.5 million for Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Vireo Growth | 10.57 Bn | 10.41 Bn | 59.30 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2019 | 285.54 Mn |
| Dec 31, 2018 | -562.79 Mn |
| Dec 31, 2017 | 166.87 Mn |